In vivo studies on riboflavin cisplatin interactions
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
According to WHO report issued on 5th June, 2010, cancer claims ~7.6 million people annually around the world. Its prevention, control and management are important fields of research since long. Many strategies have been employed for effective treatment of this disease but none of them are able to contain it effectively. Chemotherapy and radiotherapy are two main modes of treatment offered to the cancer patients and combination of the both shows better effect rather than alone. Cisplatin is the most widely used anticancer drugs under chemotherapy alone as well as in combination with other drugs together with or without radiotherapy. Its prolonged clinical usage exerts many side effects such as nephrotoxicity, hepatotoxicity, neurotoxicity and ototoxicity etc. The severity of these side effects hampers chemotherapy and worsens the sufferings of the patients. It is documented that their occurrence is probably due to the cisplatin induced oxidative and nitrosative stresses in vivo. Hence, their regulation is very important for better management of the disease, better quality of life and also for increasing life span of the patients. For the last three decades, many ameliorative agents have been tested and implemented for these stresses during chemotherapy. They include supplementation of antioxidants, vitamin-A, C and E, glutathione, melatonin, flavinoids, medicinal herbs as well as techniques like diuresis and intravenous hydration are also employed. Riboflavin is an essential hydrosoluble vitamin occurring in all forms of aerobic life. It has excellent photosensitizing property that has been used in photodynamic therapy and ribophototherapy for the treatment of various diseases.